Search

everythinglearnresearchcommunity

for

Search:↓

Activating PPAR-γ signalling can protect hair follicle stem cells from damage caused by chemotherapy.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Promising cancer treatments were found, but the manufacturer closed.

Perhexiline can effectively target ovarian cancer cells left after treatment.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

The Hr protein binds to DNA, interacts with p53, and affects cell cycle genes.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Proper diet, monitoring, and protein supplements are crucial after bariatric surgery to prevent severe malnutrition.

TCDD changes skin cell growth and keratin production in mice.

Taxol damages hair growth cells, causing hair loss.

Chemotherapy improved a girl's painful foot condition linked to pachyonychia congenita.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

The study found that analyzing certain cell signaling pathways is not a reliable method to tell apart two types of skin tumors.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Epirubicin and cyclophosphamide cause more anemia and side effects than docetaxel and cyclophosphamide, but both are equally effective.

Nested PCR can reliably identify fungal infections when traditional methods fail.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

Dental pulp stem cells are better for tissue repair, while fat tissue stem cells may be more suited for wound healing and hair growth.

Chemotherapy with carboplatin-paclitaxel causes hair loss in all patients.

A new one-step test can quickly identify skin cancer during surgery.